维普期刊资源整合服务平台（V6.5）

88篇 您的检索式：作者名="RE Buller"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Does intraperitoneal CA125reflect disease status显示文摘		1991	Gynecol Oncol1991，40，：	1
2	A phase Ⅰ/Ⅱ trial of rad/p53 (SCH 58500) gene replacement in recurrent ovarian caneer显示文摘	Buller RE Runnebaum IB Karlan BY	2002	Cancer Gene Ther2002，9，7：	1
3	Value of preoperative CA125 level in the management of uterine cancer and prediction of clinical outcome显示文摘	Sood AK Buller RE Burger RA	1997	Obstet Gynecol1997，90，3：	1
4	A phase Ⅰ /Ⅱ trial of rAd/p53 (SCH 58500) gene replaeement in recurrent ovarian cancer显示文摘	Buller RE Runnebaum IB Karlan BY	2002	Cancer Gene Ther2002，9，7：	1
5	A phase Ⅰ/ Ⅱ trial of rAd-p53 (SCH 58500) gene replacement in recurrent ovarian cancer显示文摘	Buller RE Runnebaum IB Karlan BY	2002	Cancer Gene Ther2002，9，7：	1
6	A phese Ⅰ /Ⅱ trial of rAd-P53 gene replacement in recurrent ovarian cancer显示文摘	Buller RE runnebanm IB Karlan BY	2002	Cancer Gnen Ther2002，9，7：	1
7	Extraovarian peritoneal serous papillary carcinoma case-control retrospective comparison to papillary adenocarcinoma of the ovary 显示文摘	Bloss JD Liao SY Buller RE	1993	Gynecol Oncol1993，50，3：	1
8	Extraovarian peritoneal serous papillary carcinoma 显示文摘	Bloss JD Liao SY Buller RE	1993	Gynecol Oncol1993，50，：	1
9	A phase Ⅰ/Ⅱ trial of rAd/p53(SGH 58500) gene replacement in recurrent ovarian cancer显示文摘	Buller RE Runnebaum IB Karlan BY	2002	Cancer Gene Ther2002，9，7：	1
10	The influ- ence of the p53 codon 72 polymorphism on ovarian carcinogenesis and prognosis显示文摘	Buller RE Sood A Fullenkamp C	1997	Cancer Gene Ther1997，4，4：	1
11	Drug resistance in ovarian cancer:germ the laboratory to the clinic 显示文摘	Sood AK Buller RE	1998	Obstet Gynecol1998，92，2：	1
12	Long term follow-up of patients with recurrent ovarian cancer after Adp53 gene replacement with SCH58500显示文摘	Buller RE Shahin MS Horowitz JA	2002	Cancer Gene Ther2002，30，9：	1
13	Drug resistance in ovarian cancer: from the laboratory to the clinic显示文摘	Sood AK Buller RE	1998	Obstet Gynecol1998，92，：	1
14	Extraovarian peritoneal papillary carcinoma : a case-control retrospective comparison to papillary adenocarcinoma of the ovary 显示文摘	Bloss JD Liao SY Buller RE	1993	Gyneeol Oncol1993，50，3：	1
15	Neoadjuvant chemotherapy in vulvar cancer: avoiding primary exenteration 显示文摘	Geisler JP Manahan K J Buller RE	2006	Gynecol Oncol2006，100，1：	1
16	Genomic instability in ovarian cancer:A reassessment using an arbitrarily primed polymerase chain reaction显示文摘	Sood AK Buller RE	1996	Oncogene1996，13，：	1
17	Extra ovarian peritoneal serous papillary carcin-oma:acase-control retrospective compar-ison to papillary adenocarcinoma of the ovary显示文摘	Bioss JD Liao SY Buller RE	1993	Gynecol Oncol1993，50，3：	1
18	Extraovarian peritoneal serous papillary carcinoma:a case control retrospective comparison to papillary adenocarcinoma of the ovary显示文摘	Bloss JD Liao SY Buller RE	1993	Gynecol Oncol1993，50，：	1
19	Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary artenocarcinoma of the ovary显示文摘	Bloss JD Liao SY Buller RE	1993	Gynecol Oncol1993，50，3：	1
20	The influence of the p53 codon 72 polymorphism on ovarian carcinogenesis and prognosis显示文摘	RE Buller A Sood C Fullenkamp	1997	Cancer Gene Ther1997，4，4：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示